Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ciprian Tomuleasa

Showing results (191-200 of 194) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 194 results.
JCI Insight|January 17, 2020
miR-543 regulates the epigenetic landscape of myelofibrosis by targeting TET1 and TET2Enrique Fuentes-Mattei, Recep Bayraktar, Taghi Manshouri, et al.
American Journal of Hematology|October 20, 2017
MECOM, HBS1L-MYB, THRB-RARB, JAK2, and TERT polymorphisms defining the genetic predisposition to myeloproliferative neoplasms: A study on 939 patientsAdrian P Trifa, Claudia Bănescu, Anca S Bojan, et al.
Genome Research|March 24, 2018
Cancer-associated rs6983267 SNP and its accompanying long noncoding RNA <i>CCAT2</i> induce myeloid malignancies via unique SNP-specific RNA mutationsMaitri Y Shah, Manuela Ferracin, Valentina Pileczki, et al.
Annals of Hematology|March 4, 2024
ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment optionsJean-Jacques Kiladjian, Francisca Ferrer Marin, Haifa Kathrin Al-Ali, et al.
Pageof 20

Showing results (191-200 of 194) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 194 results.
JCI Insight|January 17, 2020
miR-543 regulates the epigenetic landscape of myelofibrosis by targeting TET1 and TET2Enrique Fuentes-Mattei, Recep Bayraktar, Taghi Manshouri, et al.
American Journal of Hematology|October 20, 2017
MECOM, HBS1L-MYB, THRB-RARB, JAK2, and TERT polymorphisms defining the genetic predisposition to myeloproliferative neoplasms: A study on 939 patientsAdrian P Trifa, Claudia Bănescu, Anca S Bojan, et al.
Genome Research|March 24, 2018
Cancer-associated rs6983267 SNP and its accompanying long noncoding RNA <i>CCAT2</i> induce myeloid malignancies via unique SNP-specific RNA mutationsMaitri Y Shah, Manuela Ferracin, Valentina Pileczki, et al.
Annals of Hematology|March 4, 2024
ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment optionsJean-Jacques Kiladjian, Francisca Ferrer Marin, Haifa Kathrin Al-Ali, et al.
Pageof 20